SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/25/2017 3:28:33 PM - Followers: 31 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY
Current Price
Volume:
Bid Ask Day's Range
BMY News: CORRECTING and REPLACING Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights 05/26/2017 09:47:00 AM
BMY News: Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights 05/26/2017 06:59:00 AM
BMY News: U.S. Food & Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Application for Opdivo (nivolumab) in Pr... 05/24/2017 11:15:00 AM
BMY News: European Medicines Agency Validates Application for Bristol-Myers Squibb’s Sprycel (dasatinib) in Children with Chronic Mye... 05/19/2017 08:13:00 AM
BMY News: Bristol-Myers Squibb Research Showcases Expansive Oncology Clinical Development Program & Commitment to Exploring Novel Combi... 05/17/2017 05:00:00 PM
PostSubject
#499  Sticky Note CC transcript from Seeking Alpha: chmcnfunds 04/27/17 03:30:00 PM
#525   Impossible to decipher this stock. Yesterday by all chmcnfunds 05/25/17 03:28:33 PM
#524   U.S. Food and Drug Administration Accepts for Priority chmcnfunds 05/24/17 11:22:12 AM
#523   Bristol-Myers Squibb (BMY) Management Presents at UBS Global chmcnfunds 05/23/17 08:22:43 AM
#522   Health Canada approves OPDIVO® (nivolumab) for the treatment chmcnfunds 05/17/17 08:26:54 AM
#521   Wrong day for this blog, but has all chmcnfunds 05/16/17 02:30:35 PM
#520   Thanks, had seen that, but wasn't thinking it chmcnfunds 05/12/17 03:02:58 PM
#519   BMY slightly down due to AZN news in DewDiligence 05/12/17 02:55:55 PM
#518   Strange day. BMY usually trades in coordination with chmcnfunds 05/12/17 02:49:15 PM
#517   Roche's Loss In Bladder Cancer Lifts Astrazeneca and chmcnfunds 05/10/17 09:19:57 AM
#516   Suppose this shouldn't have impact on BMY, but FWIW: chmcnfunds 05/09/17 01:21:10 PM
#515   JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals chmcnfunds 05/05/17 02:15:58 PM
#514   You must be referencing the SA article from chmcnfunds 05/04/17 08:20:27 AM
#513   PFE may not be in the cards as 2014shelby 05/03/17 09:37:10 PM
#512   I'll leave it to the analysts who have chmcnfunds 05/03/17 08:09:36 AM
#511   What PPS do you think PFE would BO BMY? 2014shelby 05/02/17 09:31:24 PM
#510   Rumors persist: chmcnfunds 05/02/17 12:36:29 PM
#509   It's unlikely, IMO, that there will be a DewDiligence 05/01/17 06:42:10 PM
#508   Speculation prior to PFE earnings: chmcnfunds 05/01/17 03:17:08 PM
#507   Yes, but there are only a few companies DewDiligence 04/28/17 09:09:07 PM
#506   Do you think BMY is a BO candidate? 2014shelby 04/28/17 08:23:45 PM
#505   This isn't really newsworthy since the EU Commission DewDiligence 04/28/17 03:42:34 PM
#504   More good news. pps should be flying: chmcnfunds 04/28/17 03:39:10 PM
#503   Tom Lynch outlines his comeback strategy for Bristol-Myers’ chmcnfunds 04/28/17 01:22:25 PM
#502   Had noticed and was surprised that the revised chmcnfunds 04/28/17 08:38:38 AM
#501   Good news keeps coming. Surprised to see it chmcnfunds 04/28/17 08:30:18 AM
#500   PR excerpt pertaining to 2017 EPS guidance: DewDiligence 04/27/17 05:24:53 PM
#499   CC transcript from Seeking Alpha: chmcnfunds 04/27/17 03:30:00 PM
#498   Bristol-Myers Q1 top line up 12%; Opdivo sales chmcnfunds 04/27/17 09:11:54 AM
#497   Bristol-Myers Squibb Reports First Quarter Financial Results chmcnfunds 04/27/17 07:53:19 AM
#496   A ~ 40' interview of Dr. Jedd Wolchok, north40000 04/25/17 09:50:24 PM
#495   Last trade on 4/24/17: chmcnfunds 04/25/17 07:32:48 AM
#494   BMY presents positive phase-2 data BMS-986036: #msg-130715323. DewDiligence 04/22/17 03:32:45 PM
#493   See #msg-130693584 for additional color on today's approval. DewDiligence 04/21/17 02:45:39 PM
#492   EMA hands down a number of recommendations chmcnfunds 04/21/17 01:42:19 PM
#491   Anything in ASCO Planner of interest? north40000 04/20/17 06:15:45 PM
#490   No idea unless technical as was way oversold chmcnfunds 04/20/17 03:52:46 PM
#489   Why the pop on BMY at EOD? 2014shelby 04/20/17 03:34:57 PM
#488   The 4 Best Dividend Stocks in Pharmaceuticals chmcnfunds 04/19/17 10:18:52 AM
#487   Bristol-Myers Squibb Enters into Separate Agreements with Biogen chmcnfunds 04/13/17 07:42:55 AM
#486   Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for chmcnfunds 04/04/17 12:34:54 PM
#485   The Opdivo+Yervoy situation in melanoma is rather complicated; DewDiligence 04/03/17 11:47:55 AM
#484   1 for 2 today: chmcnfunds 04/03/17 11:22:38 AM
#483   Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) and chmcnfunds 04/03/17 08:43:26 AM
#482   FOMO is bad for you. Seems like BMY chmcnfunds 03/31/17 02:22:48 PM
#481   Letter mentioning BMY sent to Carl Icahn: chmcnfunds 03/27/17 03:07:02 PM
#480   Assuming MarketBeat is up-to-date their latest rating for chmcnfunds 03/27/17 01:51:48 PM
#479   Would be nice and reasonable also. Been hanging chmcnfunds 03/27/17 01:30:59 PM
#478   Or Gilead... Vita Nova Stocks 03/27/17 12:17:38 PM
#477   Not sure as to what you are questioning. chmcnfunds 03/27/17 12:16:17 PM
#476   Interesting....ex Pfizer Satish Chandran worked with BMS? as biopharm 03/27/17 11:45:46 AM
PostSubject